We are live on ! Find out more
Focus Partners Wealth

Focus Partners Wealth Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.5%
This Fund
S&P 500
This Quarter Est. Return
+3.32%
1 Year Est. Return
+20.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$87.7B
AUM Growth
+$25.8B
Cap. Flow
+$21.6B
Cap. Flow %
24.66%
Top 10 Hldgs %
20.59%
Holding
2,804
New
604
Increased
1,576
Reduced
387
Closed
159

Top Buys

Rank Stock Value
1
EQTY icon
Kovitz Core Equity ETF
EQTY
+$1.18B
2
NVDA icon
NVIDIA
NVDA
+$1.13B
3
MSFT icon
Microsoft
MSFT
+$818M
4
AAPL icon
Apple
AAPL
+$738M
5
AMZN icon
Amazon
AMZN
+$546M

Sector Composition

Rank Sector Weight
1 Technology 15.31%
2 Financials 7.86%
3 Communication Services 4.6%
4 Consumer Discretionary 4.34%
5 Healthcare 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGC
2601
Canopy Growth
CGC
$376M
$32.9K ﹤0.01%
+28,809
New +$37K
DOUG icon
2602
Douglas Elliman
DOUG
$156M
$31.6K ﹤0.01%
11,053
+5
+0% +$13
FATE icon
2603
Fate Therapeutics
FATE
$275M
$31.4K ﹤0.01%
31,966
+19,828
+163% +$23.8K
DHF
2604
BNY Mellon High Yield Strategies Fund
DHF
$170M
$29.3K ﹤0.01%
11,823
+244
+2% +$619
EDIT icon
2605
Editas Medicine
EDIT
$399M
$28.4K ﹤0.01%
13,858
-5,374
-28% -$15.5K
UP icon
2606
Wheels Up
UP
$203M
$22.1K ﹤0.01%
1,680
-1,664
-50% -$37.9K
PERF icon
2607
Perfect Corp
PERF
$197M
$20.6K ﹤0.01%
11,375
CGTX icon
2608
Cognition Therapeutics
CGTX
$80.6M
$20.3K ﹤0.01%
15,000
IAUX
2609
i-80 Gold Corp
IAUX
$1.09B
$20.1K ﹤0.01%
13,766
LAB icon
2610
Standard BioTools
LAB
$342M
$18.7K ﹤0.01%
14,643
-392
-3% -$527
LFT
2611
Lument Finance Trust
LFT
$38.6M
$18.4K ﹤0.01%
13,074
+45
+0.3% +$72
NRDY icon
2612
Nerdy
NRDY
$108M
$17.2K ﹤0.01%
16,544
+371
+2% +$418
CHGG icon
2613
Chegg
CHGG
$116M
$16.7K ﹤0.01%
+17,992
New +$19.6K
NINE
2614
DELISTED
Nine Energy Service
NINE
$15.4K ﹤0.01%
44,635
+25,500
+133% +$12.6K
RVPH
2615
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$14.8K ﹤0.01%
2,650
JOB icon
2616
GEE Group
JOB
$22.8M
$14.6K ﹤0.01%
75,084
-73,993
-50% -$14.4K
USBC
2617
USBC Inc
USBC
$119M
$14K ﹤0.01%
22,000
BZFD icon
2618
BuzzFeed
BZFD
$99M
$13.1K ﹤0.01%
14,040
-88
-0.6% -$111
SABR icon
2619
Sabre
SABR
$716M
$11.8K ﹤0.01%
+11,007
New +$19K
ONMD icon
2620
OneMedNet
ONMD
$36.6M
$11K ﹤0.01%
+10,000
New +$17.7K
RNXT icon
2621
RenovoRx
RNXT
$40.5M
$9.24K ﹤0.01%
11,000
BYND icon
2622
Beyond Meat
BYND
$274M
$9.2K ﹤0.01%
+11,213
New +$15.6K
IXHL icon
2623
Incannex Healthcare
IXHL
$34.8M
$7.62K ﹤0.01%
+709
New +$8.19K
SGMO
2624
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.62K ﹤0.01%
11,000
-5,300
-33% -$2.81K
ABR icon
2625
Arbor Realty Trust
ABR
$977M
-11,136
Closed -$136K

Similar funds

Focus Partners Wealth's Q4 2025 Portfolio in Review

As of Q4 2025, Focus Partners Wealth held 2,804 positions worth $87.7B, up 42% from $62B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Focus Partners Wealth deployed $21.6B of net new capital in Q4 2025, opening 604 new positions and adding to 1,576 existing holdings. Its largest new stake was GXO Logistics: 3,450,768 shares worth $182M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 12% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Vanguard Russell 1000 ETF, an estimated $2.64B trimmed.

  • Focus Partners Wealth's largest Q4 2025 buy was GXO Logistics: 3,450,768 shares worth $182M.
  • Focus Partners Wealth added most to Kovitz Core Equity ETF in Q4 2025, an estimated $1.18B increase.
  • Focus Partners Wealth's biggest Q4 2025 reduction was Vanguard Russell 1000 ETF, cutting an estimated $2.64B.
  • Focus Partners Wealth fully exited DoubleLine Asset-Backed Securities ETF in Q4 2025, selling an estimated $631M.
  • Focus Partners Wealth's ten largest holdings make up 21% of its $87.7B portfolio in Q4 2025.
  • Focus Partners Wealth opened 604 new positions and closed 159 in Q4 2025.
  • Focus Partners Wealth's portfolio value rose 42% quarter-over-quarter to $87.7B.

Based on Focus Partners Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.